These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23292975)

  • 61. Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes.
    Nelson DB; Partin MR; Fu SS; Joseph AM; An LC
    Nicotine Tob Res; 2009 Jan; 11(1):77-83. PubMed ID: 19246444
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EMLasso: logistic lasso with missing data.
    Sabbe N; Thas O; Ottoy JP
    Stat Med; 2013 Aug; 32(18):3143-57. PubMed ID: 23440969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Missing data and multiple imputation.
    Cummings P
    JAMA Pediatr; 2013 Jul; 167(7):656-61. PubMed ID: 23699969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.
    Song J; Boscardin WJ; Furst DE; Khanna D; Wong WK
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-122-6. PubMed ID: 25372798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analyzing longitudinal data with missing values.
    Enders CK
    Rehabil Psychol; 2011 Nov; 56(4):267-88. PubMed ID: 21967118
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imputation of missing variance data using non-linear mixed effects modelling to enable an inverse variance weighted meta-analysis of summary-level longitudinal data: a case study.
    Boucher M
    Pharm Stat; 2012; 11(4):318-24. PubMed ID: 22566382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Missing data in longitudinal studies: cross-sectional multiple imputation provides similar estimates to full-information maximum likelihood.
    Ferro MA
    Ann Epidemiol; 2014 Jan; 24(1):75-7. PubMed ID: 24210708
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Missing data: warrant for search and capture].
    Torres F; Pontes C
    Med Clin (Barc); 2013 Oct; 141(7):297-9. PubMed ID: 23706686
    [No Abstract]   [Full Text] [Related]  

  • 70. Power calculations for delta-adjusted pattern-mixture models.
    Lu K
    Stat Med; 2015 Feb; 34(5):782-95. PubMed ID: 25395021
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identifying the types of missingness in quality of life data from clinical trials.
    Curran D; Bacchi M; Schmitz SF; Molenberghs G; Sylvester RJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):739-56. PubMed ID: 9549820
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sensitivity analysis of incomplete longitudinal data departing from the missing at random assumption: Methodology and application in a clinical trial with drop-outs.
    Moreno-Betancur M; Chavance M
    Stat Methods Med Res; 2016 Aug; 25(4):1471-89. PubMed ID: 23698867
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An application of the mixed-effects model and pattern mixture model to treatment groups with differential missingness suspected not-missing-at-random.
    Gosho M; Maruo K
    Pharm Stat; 2021 Jan; 20(1):93-108. PubMed ID: 33249763
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Can one assess whether missing data are missing at random in medical studies?
    Potthoff RF; Tudor GE; Pieper KS; Hasselblad V
    Stat Methods Med Res; 2006 Jun; 15(3):213-34. PubMed ID: 16768297
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical research: a novel approach to regression substitution for handling missing data.
    Cleophas EP; Cleophas TJ
    Am J Ther; 2013; 20(5):514-9. PubMed ID: 21866042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial.
    Liublinska V; Rubin DB
    Stat Med; 2014 Oct; 33(24):4170-85. PubMed ID: 24845086
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of cross-over studies with missing data.
    Rosenkranz GK
    Stat Methods Med Res; 2015 Aug; 24(4):420-33. PubMed ID: 24501227
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Choosing estimands in clinical trials with missing data.
    Mallinckrodt C; Molenberghs G; Rathmann S
    Pharm Stat; 2017 Jan; 16(1):29-36. PubMed ID: 27492760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control-based imputation for sensitivity analyses in informative censoring for recurrent event data.
    Gao F; Liu GF; Zeng D; Xu L; Lin B; Diao G; Golm G; Heyse JF; Ibrahim JG
    Pharm Stat; 2017 Nov; 16(6):424-432. PubMed ID: 28834175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.